A 36-year-old Regina man has been charged with First Degree Murder in the Queen City’s second homicide of 2025. The victim is 42-year-old Christopher Seaton of Regina. Police and EMS were called to a ...

Kennedy, 36, of Watervliet, on April 1, 2025. Kennedy was charged with felony first-degree Rape. Kennedy was arraigned in Watervliet City Court, where he was initially remanded to the Albany ...

Sementilli’s lover, Robert Baker, now 62, pleaded no contest in July 2023 to first-degree murder and conspiracy to commit murder and admitted the two special circumstance allegations.

ELK POINT, S.D. — A 25-year-old Sioux Falls man was indicted in Union County Wednesday on 11 counts including four felony counts of attempted first-degree murder of a law enforcement officer.

A Fayetteville man charged with the first-degree murder of a minor in 2022 was transported to the Lincoln County Jail on March 31 to stand trial here. On Feb. 13, 2022, Robtavious Hawk, then 26, was ...

PINEDALE — A 19-year-old Big Piney man charged with first-degree murder and mutilation of a dead human body will be transferred from the Sublette County Detention Center in Pinedale to the Wyoming ...

CT-95 is a mesothelin x CD3 T cell engaging bispecific antibody CT-95 is Context's second T cell engaging bispecific antibody to enter the clinic in 2025 PHILADELPHIA, April 09, 2025 (GLOBE ...

Ottawa police arrested a 22-year-old man after a morning shooting in Nepean last weekend. Officials said they arrested Omar Yare and charged him with first-degree murder and attempted murder. The ...

This milestone marks Context's second active clinical trial, following the dosing of the first patient in the CTIM-76 trial earlier this year. CTIM-76 is a Claudin 6 (“CLDN6”) x CD3 TCE ...

Context Therapeutics (CNTX) announced that the first patient has been dosed in the Phase 1 clinical trial of CT-95, a mesothelin x CD3 T cell engaging bispecific antibody designed to target ...

PHILADELPHIA, April 09, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing T cell engagers for solid tumors ...